Serum cholecalciferol may be a better marker of vitamin D status than 25-hydroxyvitamin D

Medical Hypotheses

Volumn 111, Issue , 2018, Pages 61-65

  Jorde, Rolf ^a,b   Grimnes, G ^a,b  

^a UNIVERSITY OF TROMSØ   (Norway)

^b UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; CALCIFEDIOL; COLECALCIFEROL; PLACEBO; TELOMERASE; VITAMIN D; 25-HYDROXYVITAMIN D; CALCITRIOL RECEPTOR; VDR PROTEIN, HUMAN;

ARTICLE; CLINICAL PRACTICE; DIET; DRUG HALF LIFE; HUMAN; MOLECULAR BIOLOGY; OBSERVATIONAL STUDY; PLASMA HALF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SUN EXPOSURE; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION; ANALOGS AND DERIVATIVES; BLOOD; HYDROXYLATION; METABOLISM; RISK FACTOR; SKIN; SUNLIGHT; THEORETICAL MODEL;

CHOLECALCIFEROL; HUMANS; HYDROXYLATION; MODELS, THEORETICAL; OBSERVATIONAL STUDIES AS TOPIC; RECEPTORS, CALCITRIOL; RISK FACTORS; SKIN; SUNLIGHT; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 85039152043     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2017.12.017     Document Type: Article

References (52)

1. DeLuca, H.F., Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr 80 (2004), 1689S–1696S.
2. Christakos, S., Dhawan, P., Verstuyf, A., Verlinden, L., Carmeliet, G., Vitamin D: metabolism, molecular mechanism of action, and pleiotropic effects. Physiol Rev 96 (2016), 365–408.
3. Bikle, D.D., Extraskeletal actions of vitamin D. Ann N Y Acad Sci 1376 (2016), 29–52.
4. Didriksen, A., Grimnes, G., Hutchinson, M.S., Kjærgaard, M., Svartberg, J., Joakimsen, R.M., et al. The serum 25-hydroxyvitamin D response to vitamin D supplementation is related to genetic factors, BMI, and baseline levels. Eur J Endocrinol 169 (2013), 559–567.
5. Wang, T.J., Zhang, F., Richards, J.B., Kestenbaum, B., van Meurs, J.B., Berry, D., et al. Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet 376 (2010), 180–188.
6. Holick, M.F., Vitamin D deficiency. N Engl J Med 357 (2007), 266–281.
7. Theodoratou, E., Tzoulaki, I., Zgaga, L., Ioannidis, J.P., Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials. BMJ, 348, 2014, g2035.
8. Jorde, R., Grimnes, G., Vitamin D and health: the need for more randomized controlled trials. J Steroid Biochem Mol Biol 148 (2015), 269–274.
9. Ish-Shalom, S., Segal, E., Salganik, T., Raz, B., Bromberg, I.L., Vieth, R., Comparison of daily, weekly, and monthly vitamin D3 in ethanol dosing protocols for two months in elderly hip fracture patients. J Clin Endocrinol Metab 93 (2008), 3430–3435.
10. Hollis, B.W., Wagner, C.L., Clinical review: the role of the parent compound vitamin D with respect to metabolism and function: why clinical dose intervals can affect clinical outcomes. J Clin Endocrinol Metab 98 (2013), 4619–4628.
11. Zhu, J., DeLuca, H.F., Vitamin D 25-hydroxylase – four decades of searching, are we there yet?. Arch Biochem Biophys 523 (2012), 30–36.
12. Cheng, J.B., Levine, M.A., Bell, N.H., Mangelsdorf, D.J., Russell, D.W., Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase. Proc Natl Acad Sci USA 101 (2004), 7711–7715.
13. El-Atifi, M., Dreyfus, M., Berger, F., Wion, D., Expression of CYP2R1 and VDR in human brain pericytes: the neurovascular vitamin D autocrine/paracrine model. NeuroReport 26 (2015), 245–248.
14. Ma, R., Gu, Y., Zhao, S., Sun, J., Groome, L.J., Wang, Y., Expressions of vitamin D metabolic components VDBP, CYP2R1, CYP27B1, CYP24A1, and VDR in placentas from normal and preeclamptic pregnancies. Am J Physiol Endocrinol Metab 303 (2012), E928–E935.
15. Wamberg, L., Christiansen, T., Paulsen, S.K., Fisker, S., Rask, P., Rejnmark, L., et al. Expression of vitamin D-metabolizing enzymes in human adipose tissue – the effect of obesity and diet-induced weight loss. Int J Obes 37 (2013), 651–657.
16. Flanagan, J.N., Young, M.V., Persons, K.S., Wang, L., Mathieu, J.S., Whitlatch, L.W., et al. Vitamin D metabolism in human prostate cells: implications for prostate cancer chemoprevention by vitamin D. Anticancer Res 26 (2006), 2567–2572.
17. Zhu, J.G., Ochalek, J.T., Kaufmann, M., Jones, G., Deluca, H.F., CYP2R1 is a major, but not exclusive, contributor to 25-hydroxyvitamin D production in vivo. Proc Natl Acad Sci USA 110 (2013), 15650–15655.
18. Bikle, D.D., Extra renal synthesis of 1,25-dihydroxyvitamin D and its health implications. Clin Rev Bone Miner Metab 7 (2009), 114–125.
19. Dusso, A., Lopez-Hilker, S., Rapp, N., Slatopolsky, E., Extra-renal production of calcitriol in chronic renal failure. Kidney Int 34 (1988), 368–375.
20. Xie, Z., Munson, S.J., Huang, N., Portale, A.A., Miller, W.L., Bikle, D.D., The mechanism of 1,25-dihydroxyvitamin D(3) autoregulation in keratinocytes. J Biol Chem 277 (2002), 36987–36990.
21. Pryke, A.M., Duggan, C., White, C.P., Posen, S., Mason, R.S., Tumor necrosis factor-alpha induces vitamin D-1-hydroxylase activity in normal human alveolar macrophages. J Cell Physiol 142 (1990), 652–656.
22. Ritter, C.S., Haughey, B.H., Armbrecht, H.J., Brown, A.J., Distribution and regulation of the 25-hydroxyvitamin D3 1α-hydroxylase in human parathyroid glands. J Steroid Biochem Mol Biol 130 (2012), 73–80.
23. Nielsen, R., Christensen, E.I., Birn, H., Megalin and cubilin in proximal tubule protein reabsorption: from experimental models to human disease. Kidney Int 89 (2016), 58–67.
24. Leheste, J.R., Melsen, F., Wellner, M., Jansen, P., Schlichting, U., Renner-Müller, I., et al. Hypocalcemia and osteopathy in mice with kidney-specific megalin gene defect. FASEB J 17 (2003), 247–249.
25. Welsh, J., Vitamin D metabolism in mammary gland and breast cancer. Mol Cell Endocrinol 347 (2011), 55–60.
26. Abboud, M., Gordon-Thomson, C., Hoy, A.J., Balaban, S., Rybchyn, M.S., Cole, L., et al. Uptake of 25-hydroxyvitamin D by muscle and fat cells. J Steroid Biochem Mol Biol 144 (2014), 232–236.
27. Lundgren, S., Carling, T., Hjälm, G., Juhlin, C., Rastad, J., Pihlgren, U., et al. Tissue distribution of human gp330/megalin, a putative Ca(2+)-sensing protein. J Histochem Cytochem 45 (1997), 383–392.
28. Johnsen, M.S., Grimnes, G., Figenschau, Y., Torjesen, P.A., Almås, B., Jorde, R., Serum free and bio-available 25-hydroxyvitamin D correlate better with bone density than serum total 25-hydroxyvitamin D. Scand J Clin Lab Invest 74 (2014), 177–183.
29. Heaney, R.P., Armas, L.A., Shary, J.R., Bell, N.H., Binkley, N., Hollis, B.W., 25-Hydroxylation of vitamin D3: relation to circulating vitamin D3 under various input conditions. Am J Clin Nutr 87 (2008), 1738–1742.
30. Oberhelman, S.S., Meekins, M.E., Fischer, P.R., Lee, B.R., Singh, R.J., Cha, S.S., et al. Maternal vitamin D supplementation to improve the vitamin D status of breast-fed infants: a randomized controlled trial. Mayo Clin Proc 88 (2013), 1378–1387.
31. Meekins, M.E., Oberhelman, S.S., Lee, B.R., Gardner, B.M., Cha, S.S., Singh, R.J., et al. Pharmacokinetics of daily versus monthly vitamin D3 supplementation in non-lactating women. Eur J Clin Nutr 68 (2014), 632–634.
32. Dimitris, M.C., Perumal, N., Craig-Barnes, H.A., Leadley, M., Mahmud, A.A., Baqui, A.H., et al. Effect of weekly high-dose vitamin D3 supplementation on serum cholecalciferol concentrations in pregnant women. J Steroid Biochem Mol Biol 158 (2016), 76–81.
33. Martineau, A.R., Jolliffe, D.A., Hooper, R.L., Greenberg, L., Aloia, J.F., Bergman, P., et al. Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data. BMJ, 356, 2017, i6583.
34. Pilz, S., Verheyen, N., Grübler, M.R., Tomaschitz, A., März, W., Vitamin D and cardiovascular disease prevention. Nat Rev Cardiol 13 (2016), 404–417.
35. Bacchetta, J., Zaritsky, J.J., Sea, J.L., Chun, R.F., Lisse, T.S., Zavala, K., et al. Suppression of iron-regulatory hepcidin by vitamin D. J Am Soc Nephrol 25 (2014), 564–572.
36. Romagnoli, E., Mascia, M.L., Cipriani, C., Fassino, V., Mazzei, F., D'Erasmo, E., et al. Short and long-term variations in serum calciotropic hormones after a single very large dose of ergocalciferol (vitamin D2) or cholecalciferol (vitamin D3) in the elderly. J Clin Endocrinol Metab 93 (2008), 3015–3020.
37. Meyer, O., Dawson-Hughes, B., Sidelnikov, E., Egli, A., Grob, D., Staehelin, H.B., et al. Calcifediol versus vitamin D3 effects on gait speed and trunk sway in young postmenopausal women: a double-blind randomized controlled trial. Osteoporos Int 26 (2015), 373–381.
38. Jetter, A., Egli, A., Dawson-Hughes, B., Staehelin, H.B., Stöcklin, E., Gössl, R., et al. Pharmacokinetics of oral vitamin D3 and calcifediol. Bone 59 (2014), 14–19.
39. Dixon, B.M., Barker, T., McKinnon, T., Cuomo, J., Frei, B., Borregaard, N., et al. Positive correlation between circulating cathelicidin antimicrobial peptide (hCAP18/LL-37) and 25-hydroxyvitamin D levels in healthy adults. BMC Res Notes, 5, 2012, 575.
40. Zheng, J.Q., Hou, Y.C., Zheng, C.M., Lu, C.L., Liu, W.C., Wu, C.C., et al. Cholecalciferol additively reduces serum parathyroid hormone and increases vitamin D and cathelicidin levels in paricalcitol-treated secondary hyperparathyroid hemodialysis patients. Nutrients, 8, 2016 pii: E708.
41. Pasing, Y., Fenton, C.G., Jorde, R., Paulssen, R.H., Changes in the human transcriptome upon vitamin D supplementation. J Steroid Biochem Mol Biol 173 (2017), 93–99.
42. Zhu, H., Guo, D., Li, K., Pedersen-White, J., Stallmann-Jorgensen, I.S., et al. Increased telomerase activity and vitamin D supplementation in overweight African Americans. Int J Obes 36 (2012), 805–809.
43. Wagner, D., Hanwell, H.E., Schnabl, K., Yazdanpanah, M., Kimball, S., Fu, L., et al. The ratio of serum 24,25-dihydroxyvitamin D(3) to 25-hydroxyvitamin D(3) is predictive of 25-hydroxyvitamin D(3) response to vitamin D(3) supplementation. J Steroid Biochem Mol Biol 126 (2011), 72–77.
44. Christensen, M.H., Pedersen, E.K., Nordbø Y., Varhaug, J.E., Midttun, Ø., Ueland, P.M., et al. Vitamin B6 status and interferon-γ-mediated immune activation in primary hyperparathyroidism. J Intern Med 272 (2012), 583–591.
45. Grimnes, G., Joakimsen, R., Figenschau, Y., Torjesen, P.A., Almås, B., Jorde, R., The effect of high-dose vitamin D on bone mineral density and bone turnover markers in postmenopausal women with low bone mass–a randomized controlled 1-year trial. Osteoporos Int 23 (2012), 201–211.
46. Engelsen, O., Brustad, M., Aksnes, L., Lund, E., Daily duration of vitamin D synthesis in human skin with relation to latitude, total ozone, altitude, ground cover, aerosols and cloud thickness. Photochem Photobiol 81 (2005), 1287–1290.
47. Pilz, S., Hahn, A., Schön, C., Wilhelm, M., Obeid, R., Effect of two different multimicronutrient supplements on vitamin D status in women of childbearing age: a randomized trial. Nutrients, 9, 2017, 10.3390/nu9010030 pii: E30.
48. Jorde, R., Sneve, M., Emaus, N., Figenschau, Y., Grimnes, G., Cross-sectional and longitudinal relation between serum 25-hydroxyvitamin D and body mass index: the Tromsø study. Eur J Nutr 49 (2010), 401–407.
49. Michaëlsson, K., Wolk, A., Byberg, L., Mitchell, A., Mallmin, H., Melhus, H., The seasonal importance of serum 25-hydroxyvitamin D for bone mineral density in older women. J Intern Med 281 (2017), 167–178.
50. van Schoor, N.M., Lips, P., Worldwide vitamin D status. Best Pract Res Clin Endocrinol Metab 25 (2011), 671–680.
51. Brustad, M., Sandanger, T., Wilsgaard, T., Aksnes, L., Lund, E., Change in plasma levels of vitamin D after consumption of cod-liver and fresh cod-liver oil as part of the traditional north Norwegian fish dish “Mølje”. Int J Circumpolar Health 62 (2003), 40–53.
52. Little, R.R., Rohlfing, C.L., The long and winding road to optimal HbA1c measurement. Clin Chim Acta 418 (2013), 63–71.